Diabetes Insipidus

Last updated: March 22, 2026

Diabetes insipidus is an inability to concentrate urine due to a lack of antidiuretic hormone (ADH) or insensitivity to ADH in the kidneys.

Classification of diabetes inspidus

ClassificationDescriptionCauses
Central diabetes insipidusReduced secretion of ADH by the posterior pituitary glandIdiopathic, tumours, head injury, pituitary surgery, encephalitis, meningitis, Wolfram syndrome (DIDMOAD), mutations in arginine vasopressin-neurophysin II gene (AVP-NPII)
Nephrogenic diabetes insipidusThe kidneys are insensitive to ADHLithium, hypercalcaemia, hypokalaemia, kidney disease, mutation in vasopressin-2 receptor, mutation in aquaporin-2 gene
Gestational diabetes inspidusOccurs in pregnancyIncreased vasopressinase degrades ADH; increased prostaglandins make the kidneys less sensitive to ADH
Dipsogenic diabetes insipidusExcessive drinking due to impaired thirst mechanism (unquenchable thirst)Chronic meningitis, multiple sclerosis
  • Signs and symptoms
    • Polydipsia
    • Polyuria
    • Nocturia
    • Dehydration
    • Focal neurological deficits due to a space-occupying lesion
  • Physical examination
    • Dry mucous membranes
    • Poor skin turgor
    • Prolonged capillary refill time
    • Tachycardia
    • Orthostatic hypotension
    • Palpable distended bladder
  • Differentials
  • Investigations
    • 24-hour urine collection
      • Dilute urine
    • Plasma osmolality
      • Normal plasma osmolality is 285 – 295 mOsmol/kg
    • Urine and serum osmolality for the urine to plasma (U:P) osmolality ratio
      • Dilute urine with U:P < 2
    • Blood glucose to rule out diabetes
    • Serum calcium to rule out hypercalcemia
    • UECs
      • Hypenatremia
      • Dilutional hyponatremia may be present in primary polydipsia
    • 8-hour water deprivation test: evaluates the kidneys’ ability to concentrate urine. Stage 1 involves fluid deprivation and measuring serum and urine osmolality to evaluate the kidney’s concentrating ability. Stage 2 involves administering desmopressin to differentiate cranial from nephrogenic diabetes insipidus.
      • Urine osmolality > 600 mOsmol/kg in stage 1 with a U: P ratio> 2 for normal concentrating ability
      • Urine concentrates less than normal in primary polydipsia
      • Urine osmolality is increased to > 600 mOsmol/kg after desmopressin
      • No increase in urine osmolality after desmopressin in nephrogenic diabetes insipidus
    • Serum copeptin – copeptin is a surrogate marker for ADH (it is produced in equimolar amounts from its precursor)
      • Low copeptin in central diabetes insipidus
      • High copeptin in nephrogenic diabetes insipidus
  • Treatment
    • Correct any underlying causes
    • A low-solute diet to reduce osmotic load
    • Adequate fluid intake
    • Avoid rapid correction of hypernatremia
    • Desmopressin for central diabetes insipidus
    • Thiazide diuretics (endroflumethiazide) or NSAIDs can be used for nephrogenic diabetes insipidus
      • Prostaglandins locally inhibit the action of ADH
  • Emergency treatment
    • Urgent UECs, serum and urine osmolality
    • Monitor serum Na+, urine output and fluid balance
    • Intravenous fluids to maintain urine output and to correct hypernatremia
    • Trial of desmopressin

Interpretation of the water deprivation test

DiagnosisSerum osmolality (mOsm/kg)Urine osmolality (mOsm/kg)Urine osmolality after desmopressin given (mOsm/kg)
Normal285-295>600Not completed as normal results
Dipsogenic diabetes inspipidus<300400-600No change
Cranial diabetic insipidus>300<300Urine concentrates following desmopressin administration
Nephrogenic diabetes insipidus>300< 300No change following desmopressin
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *